Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Feb;37(2):171–189. doi: 10.1038/bjc.1978.25

Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid.

P A Keep, B A Leake, G T Rogers
PMCID: PMC2009599  PMID: 204321

Abstract

The use of perchloric acid and water for the extraction of CEA from tumour and foetal tissues has been investigated. In the case of tumour, lower recoveries of CEA were obtained from perchloric acid extracts than from aqueous extracts of the same tissue. CEA has also been extracted with 3M KCl solution from insoluble perchloric acid residues of tumour homogenates and cancer patients' serum. Whilst a large proportion of CEA activity recovered from tumour was associated with the perchloric acid residue, the corresponding amounts from serum were very small. CEA elution volumes for each extract, obtained by assay of Sephadex G-200 column fractions, showed significant heterogeneity in molecular size. The purified CEA pools also showed quantitative variations in the binding profiles on Con A-Sepharose. It has been shown that perchloric acid modifies the carbohydrate in CEA, thus altering its Con A-binding properties. Preliminary experiments with foetal colon have demonstrated that, unlike colorectal CEA, a significant proportion of foetal CEA was not bound to ConA. Comparative immunodiffusion showed immunological identity of CEA from the various extracts, although the purified aqueous extract produced an additional precipitin reaction, indicating a second antigen which is relatively unstable or less soluble in perchloric acid.

Full text

PDF
171

Images in this article

180Fig. 5
on p.180

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashman L. K., Ludbrook J., Marshall V. R. Comparison of whole plasma and perchloric acid-extracted plasma assays for carcinoembryonic antigen. Clin Chim Acta. 1977 Jan 3;74(1):77–84. doi: 10.1016/0009-8981(77)90390-4. [DOI] [PubMed] [Google Scholar]
  2. Brattain M. G., Jones C. M., Pittman J. M., Pretlow T. G. The purification of carcinoembryonic antigen by glutaraldehyde cross-linked concanavalin A. Biochem Biophys Res Commun. 1975 Jul 8;65(1):63–67. doi: 10.1016/s0006-291x(75)80061-1. [DOI] [PubMed] [Google Scholar]
  3. Carrico R. J., Usategui-Gomez M. The isolation of carcinoembryonic antigen from tumor tissue at neutral pH. Cancer Res. 1975 Nov;35(11 Pt 1):2928–2934. [PubMed] [Google Scholar]
  4. Coligan J. E., Henkart P. A., Todd C. W., Terry W. D. Heterogeneity of the carcinoembryonic antigen. Immunochemistry. 1973 Sep;10(9):591–599. doi: 10.1016/0019-2791(73)90160-2. [DOI] [PubMed] [Google Scholar]
  5. Coligan J. E., Lautenschleger J. T., Egan M. L., Todd C. W. Isolation and characterization of carcinoembryonic antigen. Immunochemistry. 1972 Apr;9(4):377–386. doi: 10.1016/0019-2791(72)90308-4. [DOI] [PubMed] [Google Scholar]
  6. Darcy D. A., Turberville C., James R. Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein. Br J Cancer. 1973 Aug;28(2):147–160. doi: 10.1038/bjc.1973.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edgington T. S., Astarita R. W., Plow E. F. Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. N Engl J Med. 1975 Jul 17;293(3):103–107. doi: 10.1056/NEJM197507172930301. [DOI] [PubMed] [Google Scholar]
  8. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Khoo S. K., Mackay I. R. Carcinoembryonic antigen in serum in diseases of the liver and pancreas. J Clin Pathol. 1973 Jul;26(7):470–475. doi: 10.1136/jcp.26.7.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Khoo S. K., Warner N. L., Lie J. T., Mackay I. R. Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int J Cancer. 1973 May;11(3):681–687. doi: 10.1002/ijc.2910110319. [DOI] [PubMed] [Google Scholar]
  11. Krupey J., Wilson T., Freedman S. O., Gold P. The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry. 1972 Jun;9(6):617–622. doi: 10.1016/0019-2791(72)90247-9. [DOI] [PubMed] [Google Scholar]
  12. Martin F., Martin M. S., Bordes M., Bourgeaux C. The specificity of carcino-foetal antigens of the human digestive-tract tumours. Eur J Cancer. 1972 Jun;8(3):315–321. doi: 10.1016/0014-2964(72)90027-8. [DOI] [PubMed] [Google Scholar]
  13. Pletsch Q., Goldenberg D. M. Molecular size of carcinoembryonic antigen in the plasma of patients with malignant disease. J Natl Cancer Inst. 1974 Nov;53(5):1201–1204. doi: 10.1093/jnci/53.5.1201. [DOI] [PubMed] [Google Scholar]
  14. Pritchard D. G., Todd C. W. Purification of carcinoembryonic antigen by removal of contaminating mucopolysaccharides. Cancer Res. 1976 Dec;36(12):4699–4701. [PubMed] [Google Scholar]
  15. Pusztaszeri G., Mach J. P. Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry. 1973 Mar;10(3):197–204. doi: 10.1016/0019-2791(73)90008-6. [DOI] [PubMed] [Google Scholar]
  16. Rogers G. T. Heterogeneity of carcinoembryonic antigen. Implications on its role as a tumour marker substance. Biochim Biophys Acta. 1976 Dec 23;458(4):355–373. doi: 10.1016/0304-419x(76)90007-x. [DOI] [PubMed] [Google Scholar]
  17. Rogers G. T., Leake B. A., Searle F., Bagshawe K. D. Heterogeneity and specificity of circulating carcinoembryonic antigen. Eur J Cancer. 1977 Mar 29;13(3):293–295. doi: 10.1016/0014-2964(77)90218-3. [DOI] [PubMed] [Google Scholar]
  18. Rogers G. T., Searle F., Bagshawe K. D. Carcinoembryonic antigen: isolation of a sub-fraction with high specific activity. Br J Cancer. 1976 Apr;33(4):357–362. doi: 10.1038/bjc.1976.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rogers G. T., Searle F., Bagshawe K. D. Heterogeneity of carcinoembryonic antigen and its fractionation by con A affinity chromatography. Nature. 1974 Oct 11;251(5475):519–521. doi: 10.1038/251519a0. [DOI] [PubMed] [Google Scholar]
  20. Rogers G. T., Searle F., Wass M. Immunological and chemical studies on sub-fractions of carcinoembryonic antigen. Immunochemistry. 1975 Oct;12(10):839–842. doi: 10.1016/0019-2791(75)90149-4. [DOI] [PubMed] [Google Scholar]
  21. Rule A. H., Goleski-Reilly C. Carcinoembryonic antigen (CEA) "fingerprints". Br J Cancer. 1973 Nov;28(5):464–468. doi: 10.1038/bjc.1973.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rule A. H., Goleski-Reilly C. Carcinoembryonic antigen (CEA): separation of CEA-reacting molecules from tumor, fetal gut, meconium and normal colon. Immunol Commun. 1973;2(2):213–226. doi: 10.3109/08820137309022793. [DOI] [PubMed] [Google Scholar]
  23. Slayter H. S., Coligan J. E. Characterization of carcinoembryonic antigen fractionated by concanavalin A chromatography. Cancer Res. 1976 May;36(5):1696–1704. [PubMed] [Google Scholar]
  24. Sorokin J. J., Kupchik H. Z., Zamcheck N. Brief communication: carcinoembryonic antigen in colon cancer: absence in perchloric acid precipitates of plasma. J Natl Cancer Inst. 1973 Sep;51(3):1081–1083. doi: 10.1093/jnci/51.3.1081. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES